While the development of selective and potent HDAC8is both as chemical probes and drug candidates remains crucial, the multi-target pharmacological approach on HDAC8 has recently gained attention since achieving the simultaneous modulation of multiple targets could offer several benefits, especially in complex diseases such as cancer, CNS diseases and fibrosis [158]. Here, HDAC8 is linked to cancer.